These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8277097

  • 1. Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction.
    Purvis JA, McNeill AJ, Siddiqui RA, Roberts MJ, McClements BM, McEneaney D, Campbell NP, Khan MM, Webb SW, Wilson CM.
    J Am Coll Cardiol; 1994 Jan; 23(1):6-10. PubMed ID: 8277097
    [Abstract] [Full Text] [Related]

  • 2. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL.
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [Abstract] [Full Text] [Related]

  • 3. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study.
    Verheugt FW, Liem A, Zijlstra F, Marsh RC, Veen G, Bronzwaer JG.
    J Am Coll Cardiol; 1998 Feb; 31(2):289-93. PubMed ID: 9462569
    [Abstract] [Full Text] [Related]

  • 4. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC, Tanswell P, Dechend R, Sosada M, Weis A, Waigand J, Uhlich F, Hauck S, Jost S, Rafflenbeul W, Lichtlen PR, Dietz R.
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [Abstract] [Full Text] [Related]

  • 5. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
    Zarich SW, Kowalchuk GJ, Weaver WD, Loscalzo J, Sassower M, Manzo K, Byrnes C, Muller JE, Gurewich V.
    J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C, Smalling RW, Berg G, Burnett C, Lorch G, Kalbfleisch JM, Chernoff R, Christie LG, Feldman RL, Seals AA, Weaver WD.
    Circulation; 1996 Sep 01; 94(5):891-8. PubMed ID: 8790022
    [Abstract] [Full Text] [Related]

  • 7. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW, Bode C, Kalbfleisch J, Sen S, Limbourg P, Forycki F, Habib G, Feldman R, Hohnloser S, Seals A.
    Circulation; 1995 Jun 01; 91(11):2725-32. PubMed ID: 7758177
    [Abstract] [Full Text] [Related]

  • 8. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C, Nordt TK, Peter K, Smalling RW, Runge MS, Kübler W.
    Am J Cardiol; 1996 Dec 19; 78(12A):16-9. PubMed ID: 8990406
    [Abstract] [Full Text] [Related]

  • 9. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U, Windeler J, Boesl I, Hoffmann H, Wojcik J, Ashmawy M, Rüdiger Schwarz E, von Loewis P, Rosemeyer P, Hopkins G.
    J Am Coll Cardiol; 1995 Aug 19; 26(2):365-73. PubMed ID: 7608436
    [Abstract] [Full Text] [Related]

  • 10. ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.
    Malcolm AD, Keltai M, Walsh MJ.
    Eur Heart J; 1996 Oct 19; 17(10):1522-31. PubMed ID: 8909909
    [Abstract] [Full Text] [Related]

  • 11. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS).
    Neuhaus KL, von Essen R, Tebbe U, Vogt A, Roth M, Riess M, Niederer W, Forycki F, Wirtzfeld A, Maeurer W.
    J Am Coll Cardiol; 1992 Apr 19; 19(5):885-91. PubMed ID: 1552106
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG, Laperche T, Golmard JL, Juliard JM, Benamer H, Himbert D, Aubry P.
    J Am Coll Cardiol; 1998 Mar 15; 31(4):776-9. PubMed ID: 9525545
    [Abstract] [Full Text] [Related]

  • 13. Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
    Neuhaus KL, von Essen R, Vogt A, Tebbe U, Rustige J, Wagner HJ, Appel KF, Stienen U, König R, Meyer-Sabellek W.
    J Am Coll Cardiol; 1994 Jul 15; 24(1):55-60. PubMed ID: 8006283
    [Abstract] [Full Text] [Related]

  • 14. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
    Arnout J, Simoons M, de Bono D, Rapold HJ, Collen D, Verstraete M.
    J Am Coll Cardiol; 1992 Sep 15; 20(3):513-9. PubMed ID: 1512327
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction.
    Purvis JA, Trouton TG, Roberts MJ, McKeown P, Mulholland MG, Dalzell GW, Wilson CM, Patterson GC, Webb SW, Khan MM.
    Am J Cardiol; 1991 Dec 15; 68(17):1570-4. PubMed ID: 1746456
    [Abstract] [Full Text] [Related]

  • 16. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM.
    J Am Coll Cardiol; 1998 Sep 15; 32(3):641-7. PubMed ID: 9741505
    [Abstract] [Full Text] [Related]

  • 17. Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction.
    Tranchesi B, Chamone DF, Cobbaert C, Van de Werf F, Vanhove P, Verstraete M.
    Am J Cardiol; 1991 Jul 15; 68(2):161-5. PubMed ID: 1829574
    [Abstract] [Full Text] [Related]

  • 18. HBW 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of coronary reocclusion in acute myocardial infarction: results of a dose-finding study (HIT-II) by the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte.
    von Essen R, Zeymer U, Tebbe U, Jessel A, Kwasny H, Mateblowski M, Niederer W, Wagner J, Mäurer W, von Leitner ER, Haerten K, Roth M, Neuhaus KL.
    Coron Artery Dis; 1998 Jul 15; 9(5):265-72. PubMed ID: 9710686
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
    Hackett D, Andreotti F, Haider AW, Brunelli C, Shahi M, Fussell A, Buller N, Foale R, Lipkin D, Caponnetto S.
    Am J Cardiol; 1992 Jun 01; 69(17):1393-8. PubMed ID: 1590225
    [Abstract] [Full Text] [Related]

  • 20. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.
    Wallentin L, Bergstrand L, Dellborg M, Fellenius C, Granger CB, Lindahl B, Lins LE, Nilsson T, Pehrsson K, Siegbahn A, Swahn E.
    Eur Heart J; 2003 May 01; 24(10):897-908. PubMed ID: 12714021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.